Stockscreener 앱 받기
0.42%
시간 외 거래:
전일 마감가:
$183.09
열려 있는:
$183.96
하루 거래량:
2.10M
Relative Volume:
2.60
시가총액:
$11.73B
수익:
$13.84B
순이익/손실:
$1.10B
주가수익비율:
17.65
EPS:
10.4185
순현금흐름:
$1.49B
1주 성능:
+1.27%
1개월 성능:
+3.34%
6개월 성능:
+23.54%
1년 성능:
+41.18%
1일 변동 폭
$181.27
$185.84
1주일 범위
$181.27
$195.75
52주 변동 폭
$101.00
$247.49
다비타 Stock (DVA) Company Profile
명칭
Davita Inc
전화
310-536-2668
주소
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, EHC, FMS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
183.86 | 11.58B | 13.84B | 1.10B | 1.49B | 10.42 |
HCA
Hca Healthcare Inc
|
427.71 | 92.43B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
261.99 | 21.23B | 21.46B | 2.65B | 3.35B | 19.23 |
EHC
Encompass Health Corp
|
121.75 | 12.01B | 6.07B | 793.80M | 464.40M | 5.9914 |
FMS
Fresenius Medical Care Ag Adr
|
22.20 | 11.90B | 22.44B | 1.35B | 2.03B | 1.9002 |
다비타 Stock (DVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-03-06 | 개시 | Barclays | Equal Weight |
| 2023-08-07 | 업그레이드 | UBS | Neutral → Buy |
| 2022-11-01 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-10-31 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-08-19 | 재개 | UBS | Buy |
| 2022-06-21 | 재확인 | BofA Securities | Underperform |
| 2021-09-10 | 개시 | Cowen | Market Perform |
| 2021-08-12 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2021-03-26 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-01-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-01-24 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-11-07 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | 업그레이드 | UBS | Sell → Neutral |
| 2019-01-03 | 개시 | Deutsche Bank | Buy |
| 2018-12-14 | 개시 | Barclays | Overweight |
| 2018-11-28 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | 개시 | UBS | Sell |
| 2018-11-08 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2018-01-04 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2017-12-07 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2017-06-26 | 다운그레이드 | Jefferies | Buy → Hold |
| 2016-12-13 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
모두보기
다비타 주식(DVA)의 최신 뉴스
DaVita Inc. stock advances as Q2 2026 earnings and guidance underpin strong valuation - ad-hoc-news.de
DaVita Community Care Report 2025: Our Journey to Net Zero - ACCESS Newswire
DaVita stock heads into the open after a 1.9% gain - ad-hoc-news.de
DaVita to pay $15M to settle data breach lawsuit - Tri-Cities Area Journal of Business
DaVita Inc. stock gains as guidance and earnings support strong 2026 outlook - ad-hoc-news.de
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now - Yahoo Finance
DaVita stock heads into the open after a 0.9% gain - ad-hoc-news.de
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Commitment to Helping Communities Thrive: DaVita Community Care Report 2025 - accessnewswire.com
DaVita Inc. stock holds near recent highs on solid Q2 2026 earnings and guidance - ad-hoc-news.de
DaVita stock heads into the open after a flat prior close - ad-hoc-news.de
DaVita Inc. stock gains support from solid Q2 2026 earnings - ad-hoc-news.de
DaVita Inc. (DVA) Stock Analysis: Evaluating the 18.72% Upside Potential for Healthcare Investors - DirectorsTalk Interviews
DaVita Inc. stock gains on solid Q1 figures and buybacks - ad-hoc-news.de
DaVita $15M Data Breach Settlement Hits 2.4M Patients - tech-insider.org
DaVita stock gains as Humana expands kidney care - ad-hoc-news.de
Healthcare August recap: Moderna jumps 156% as biotech shines; DaVita sinks - Seeking Alpha
DaVita $15M Data Breach Settlement 2026: What It Pays - shattered.io
NewsDaVita to pay $15 million to settle data breach lawsuit affecting millions of dialysis patients - teiss
DaVita Community Care Report 2025: Leading With Integrity and Accountability - ACCESS Newswire
DaVita Reaches Preliminary Settlement Class Agreement Following Ransomware Attack - Benzinga
DaVita (DVA) Has Investors Asking A Fresh Question - Yahoo Finance
DaVita Inc. stock gains support from higher earnings and steady guidance - ad-hoc-news.de
DaVita (DVA) Q2 2026 Earnings Call Transcript - Fortune
DaVita agrees to pay $15M to settle claims from data breach - MedTech Dive
DaVita Inc. stock holds near 179 dollars after strong 2026 earnings momentum - ad-hoc-news.de
Why Is DaVita HealthCare (DVA) Down 4.9% Since Last Earnings Report? - Yahoo Finance
Do Options Traders Know Something About DaVita Stock We Don't? - TradingView
DaVita Inc. stock gains after data breach settlement and partnership expansion - ad-hoc-news.de
DaVita (NYSE:DVA): Is the Humana Deal Unlocking More Value? - Kalkine Media
DaVita Agrees to Pay $15 Million to Settle Data Breach Litigation - The HIPAA Journal
DaVita stock trades around $180 as Q2 2026 growth and kidney-care partnership shape expectations - AD HOC NEWS
DaVita Inc. stock underperforms Monday when compared to competitors - MarketWatch
DaVita stock holds $180.72 as earnings beat and guidance stand out - ad-hoc-news.de
Zacks Industry Outlook Highlights DaVita, LifeStance Health, Option Care Health, and Aveanna Healthcare - Yahoo Finance
DaVita Inc. (DVA) Stock Analysis: Strong EPS and Growth Potential Highlight Investment Opportunity - DirectorsTalk Interviews
At US$180, Is DaVita Inc. (NYSE:DVA) Worth Looking At Closely? - Moomoo
Will DaVita’s (DVA) Expanded Humana CKD Partnership Reshape Its Value-Based Care Narrative? - simplywall.st
DaVita stock steadies as new Humana partnership follows strong Q2 results - ad-hoc-news.de
Enterprise value to revenue forward of DaVita Inc. – NYSE:DVA - TradingView
Davita Inc. Announces New Value-Based Partnership with Humana Inc. to Expand Care for Patients with Chronic Kidney Disease - marketscreener.com
DaVita partners with Humana on kidney disease care program - investing.com
DaVita Defeats Nurse Overtime Collective Bid - law360.com
DaVita stock holds a solid valuation as investors digest recent earnings and ratings - ad-hoc-news.de
DaVita dialysis clinic in Novi has repeated deficiencies as families demand answers after 2 deaths - WXYZ Channel 7
Wealthfront Advisers LLC Buys Shares of 10,596 DaVita Inc. $DVA - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Takes Position in DaVita Inc. $DVA - MarketBeat
Danske Bank A S Invests $13.11 Million in DaVita Inc. $DVA - MarketBeat
DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch
DaVita stock steadies after Q2 revenue growth but EPS outlook disappoints - Ad-hoc-news.de
다비타 (DVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.59%
1.13%
자본화:
|
볼륨(24시간):